STAA Bear trend not borkenSTAA even with strong fundamentals is still bearish territory
its in a bearish trend and only breaking above 60$ mark is a confirmation of a bullish reversal
Until then just keep watching it slide :)
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.40 EUR
19.34 M EUR
292.11 M EUR
48.96 M
About STAAR Surgical Company
Sector
Industry
CEO
Thomas G. Frinzi
Website
Headquarters
Lake Forest
Founded
1982
FIGI
BBG000GMV605
STAAR Surgical Co. engages in the design, development, manufacture, and sale of ophthalmic surgical products. The firm offers implantable lenses for the eye and accessory delivery systems. Its products include refractive and cataract solutions through the Collamer brand. The company was founded in 1982 and is headquartered in Lake Forest, CA.
STAA medical suppy small cap catching up from Covid LONGSTAA is a medical company specialized in implantable lenses. Many of those needing
lens replacements for cataracts put things off during the COVID era and eye surgeons are now
catching up on backed up patient loads. Medical insurance companies are burdened with
patients catching up from the cov
STAA Long Idea ~150% increaseI started keeping an eye on the stock when the bull flag began forming.
Yesterday we had a breakout confirmation from the bullish flag. As long as the breakout continues, we could reach the first Target/Take Profit at $98 per share with a 37% Profit.
If the earnings report which follows soon after
STAA Nice continuation pattern. Investors seems to be getting very bullish on this company. The fundamentals fit the profile.
$STAA Quality Growth Stock$STAA potential quality growth stock that is acting very well considering the bear market we are in.
Needs a bit more work but promising price action so far.
Putting it on our radar for now.
STAA - Likely bottomed outA downtrend that had reverted to forming a base in the past 2.5 months with "neckline" at 85.50 +/-.
There was a strong gap of abt 10% on 28 March on huge volume which hit right into the horizontal resistence around 85.50 and experiencing some pullback since.
As this is likely a "breakaway gap" (a
Mark Minervini's Style Analysisconditions:
1) trend in place (all ma in right order)
2) price held by EMA50, and continue EMA21 as support
3)correction from prev. ATH: ~20%
4)nice looking C&H pattern with vcp, higher low
5)good volumes with buyer stepped in when price increases
6) trade risk: 4.87%
7)on BO day, volume double than
STAA 30m Wolfe Wave bullish 11/26The trend is still down and the dotted line is still down. I personally would not take this A Wolfe Wave is a chart pattern composed of five wave patterns in price that imply an underlying equilibrium price. Investors who use this system time their trades based upon the resistance and support lines
STAA 4h Wolfe Wave bullish 11/17A Wolfe Wave is a chart pattern composed of five wave patterns in price that imply an underlying equilibrium price. Investors who use this system time their trades based upon the resistance and support lines indicated by the pattern.
STAA - Cup with Handle Brekout @ ~$157STAA has developed a 3 month cup with handle pattern, with breakout of $157. Might be good opportunity to buy for a 5-8% profit target
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange STAAR SURGICAL CO. DL-,01 stocks are traded under the ticker SR3.
We've gathered analysts' opinions on STAAR SURGICAL CO. DL-,01 future price: according to them, SR3 price has a max estimate of 48.39 EUR and a min estimate of 25.62 EUR. Watch SR3 chart and read a more detailed STAAR SURGICAL CO. DL-,01 stock forecast: see what analysts think of STAAR SURGICAL CO. DL-,01 and suggest that you do with its stocks.
Yes, you can track STAAR SURGICAL CO. DL-,01 financials in yearly and quarterly reports right on TradingView.
STAAR SURGICAL CO. DL-,01 is going to release the next earnings report on Feb 19, 2025. Keep track of upcoming events with our Earnings Calendar.
SR3 earnings for the last quarter are 0.23 EUR per share, whereas the estimation was 0.16 EUR resulting in a 44.56% surprise. The estimated earnings for the next quarter are −0.03 EUR per share. See more details about STAAR SURGICAL CO. DL-,01 earnings.
STAAR SURGICAL CO. DL-,01 revenue for the last quarter amounts to 79.57 M EUR, despite the estimated figure of 78.05 M EUR. In the next quarter, revenue is expected to reach 73.22 M EUR.
SR3 net income for the last quarter is 8.96 M EUR, while the quarter before that showed 6.89 M EUR of net income which accounts for 30.11% change. Track more STAAR SURGICAL CO. DL-,01 financial stats to get the full picture.
No, SR3 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 21, 2024, the company has 1.11 K employees. See our rating of the largest employees — is STAAR SURGICAL CO. DL-,01 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. STAAR SURGICAL CO. DL-,01 EBITDA is 28.37 M EUR, and current EBITDA margin is 10.30%. See more stats in STAAR SURGICAL CO. DL-,01 financial statements.
Like other stocks, SR3 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade STAAR SURGICAL CO. DL-,01 stock right from TradingView charts — choose your broker and connect to your account.